Publications by authors named "James Yy Fung"
Recurrent pyogenic cholangitis: An indication for liver transplantation.
Hepatobiliary Pancreat Dis Int
August 2022
Donor ductal anomaly is not a contraindication to right liver lobe donation.
Hepatobiliary Pancreat Dis Int
August 2019
Article Synopsis
- A study was done to see if certain types of bile duct anatomy in liver donors affected complications after living-donor liver transplants.
- They looked at two groups of patients: those who had problems (like bile duct narrowing) and those who didn't, comparing their donors' bile duct types.
- The results showed that the type of bile duct anatomy in donors didn’t really affect the risk of problems for either the donors or the recipients.
Emergency ABO-incompatible living donor liver transplant for patients with ultrahigh MELD scores.
Hepatobiliary Pancreat Dis Int
February 2019
Aim: To analyze the outcomes of living-donor liver transplantation (LDLT) using left-lobe (LL) or right-lobe (RL) small-for-size (SFS) grafts.
Methods: Prospectively collected data of adult patients who underwent LDLT at our hospital in the period from January 2003 to December 2013 were reviewed. The patients were divided into the RL-LDLT group and the LL-LDLT group.
Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.
Expert Opin Emerg Drugs
June 2017
Acute and chronic graft rejection continues to be an important problem after solid organ transplantation. With the introduction of potent immunosuppressive agents such as calcineurin inhibitors, the risk of rejection has been significantly reduced. However, the adverse effects of life-long immunosuppression remain a concern, and there exist a fine balance between over-immunosuppression and risk of rejection.
View Article and Find Full Text PDFArticle Synopsis
- There’s a big debate about whether people with high MELD scores (a measure for liver health) should get liver transplants from living donors.
- In this study, researchers looked at 143 patients who had liver transplants and split them into two groups: high MELD scores (25 or more) and low MELD scores (less than 25).
- They found that even though patients with high MELD scores had more complications after surgery, their chances of survival after one, three, and five years were similar to those with lower scores, meaning they can still safely get transplants.